Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In the STEP clinical program, patients receiving 2.4 mg weekly demonstrated greater weight lossapproximately 18% of baseline body weightcompared to those at lower doses over 68 weeks
Contact your healthcare provider if fatigue is severe, worsens progressively, prevents work or daily activities, or accompanies concerning symptoms like chest pain, confusion, or fainting
choose enteric-coated or triglyceride-form products and adjust dose if you notice worsening nausea during tirzepatide titration, using reputable DHA/EPA omega-3 supplements as needed and under guidance if you take anticoagulant or antiplatelet medicines
June 28, 2024: Study Reveals Potential Bone Density Reduction with GLP-1 Treatment In a recent study, Simon Jensen, Ph.D., and others found that GLP-1 treatment, without exercise, could lead to reduced bone density
